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We report the first laboratory-confirmed human infec-
tion with O’nyong-nyong virus in Chad. This virus was iso-
lated from peripheral blood mononuclear cells of a patient
with evidence of a seroconversion to a virus related to
Chikungunya virus. Genome sequence was partly deter-
mined, and phylogenetic studies were conducted.
O
n November 2, 2004, a febrile 19-year-old French sol-
dier staying in Chad and returning from a mission in
Sarh, in the southern part of the country, was admitted to
the hospital. Clinical examination showed a high body
temperature (38°C), rash, periocular erythema, and
pharyngitis. Abdominal, cardiopulmonary, and neurologic
functions were normal. Except for body temperature, bio-
chemical and hematologic values were normal. Serologic
results were negative for Rickettsia typhi,  R. conorii,
Legionella pneumophila,  Bordetella pertussis, HIV, and
human herpesviruses 1 and 2. Results of malaria testing
were also negative. The patient received intravenous
acetaminophen for 2 days, according to the protocol used
by the French Armed Forces Medical Service in the event
of fever occurring overseas. He recovered after 5 days
without sequelae.
Serum samples, collected during the acute phase
(November 3–5, 2004) and after (November 23 and
December 7, 2004; January 10 and February 1, 2005)
were transported to our laboratory and tested by ELISA
for immunoglobulin M (IgM) and IgG antibodies to a bat-
tery of arboviruses by IgM-antibody capture (MAC-
ELISA) and antigen-capture ELISA, respectively (1).
Each serum sample was considered positive if the optical
density (OD) ratio, OD (viral antigen)/OD (uninfected
cells), was >3. The first sample (November 3, 2004) con-
tained no antibodies (OD ratio <2) to dengue viruses,
West Nile virus, Wesselsbron virus, Rift Valley fever
virus, Bunyamwera virus, or Chikungunya virus
(CHIKV). Remaining samples contained antibodies to a
virus serologically related to CHIKV (OD ratios >3) for
both IgM (sample 2 and following samples) and IgG
(sample 3 and those following). Antibody titers peaked 20
days (IgM) and 68 days (IgG) after the onset of symptoms
(Figure 1). The IgM titer returned to a low level within 2
months after onset of illness.
Results of CHIKV-specific real-time reverse transcrip-
tion–PCRs (2) performed with serum samples as templates
were negative. Virus isolation was attempted by incubation
of peripheral blood mononuclear cells collected on the day
of onset with C6/36 (Aedes albopictus) and Vero (E6
clone) monolayers. After 5 days, supernatants were col-
lected and used to infect fresh cell cultures. After 2 days,
cytopathologic effects were observed in Vero monolayers;
a high level of cell death was also observed in C6/36 cells.
Infected Vero and C6/36 cells were then examined by indi-
rect immunofluorescence assay (IFA) for 8 different
alphaviruses with alphavirus-specific antibodies and in-
house mouse hyperimmune ascitic fluids to CHIKV,
Mayaro (MAYV), Tonate (TONV), Semliki Forest (SFV),
and Sindbis (SINV) viruses. Results of IFA were positive
when alphavirus-specific antibodies and antibodies to
CHIKV, MAYV, and TONV were used; no fluorescence
was observed when antibodies to SFV and SINV were
used at the dilution 1:200.
CHIKV-specific real-time RT-PCRs were negative
when cell culture supernatants were used as samples; this
result excluded CHIKV as the etiologic agent. We next
used cM3W and M2W2 alphavirus-specific primers (3) to
partially amplify viral genome by RT-PCR. The RT-PCR
product was sequenced (GenBank accession no.
DQ381540, isolate IMTSSA/5163) and used in a BLAST
search that identified O’nyong-nyong virus (ONNV, E
value 6e–130).
Viral RNA was amplified for phylogenetic studies by
using ONNV-specific primers for nsP3, E2, and E1
sequences (primer sequences are available on request). RT-
PCR products (614, 728, and 1080-nt long, respectively)
were sequenced (GenBank accession nos. DQ383272,
DQ383273, and DQ399055, respectively) and compared
with ONNV sequences available on GenBank database;
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Figure 1. Immunoglobulin M (IgM) () and IgG (S) titer in serum.
For all samples, antibody titers were determined by serial dilution
assays. Antibody titer is defined as the reciprocal of the highest
dilution of serum that yields a positive serologic reaction.alignments were performed with ClustalW 1.7 software.
Comparison of partial sequences showed a high degree of
homology between the virus we isolated in Chad and
strains previously isolated. In all 4 regions sequenced,
paired identity at the nucleotide and amino acid level
ranged from 92% to 98% and from 95% to 98%, respec-
tively. Compared with ONNV isolate Gulu, the nsP3
sequence of our isolate featured a glycine-encoding codon
deletion (nt 5249–5251, according to ONNV strain Gulu
numbering). This deletion was also observed in ONNV
strains SG650 and IbH10964, which might indicate a com-
mon lineage.
Four phylograms were constructed, each based on 1
genomic region we sequenced. Among ONNV sequences,
all 4 phylograms exhibited a similar pattern: ONNVisolate
IbH 10964 (Nigeria) and ONNV strain SG650 (Uganda)
seemed to be closely related, whereas isolates Gulu
(Uganda) and IMTSSA/5163 (Chad) were placed in 2 dif-
ferent branches (100% bootstrap value in the 4 phylo-
grams). The phylogenetic tree based on E1-encoding
sequence (1080-nt long) gave the opportunity to include 2
other ONNV sequences (Figure 2).
ONNV (family  Togaviridae, genus Alphavirus) was
first isolated from human blood and anopheline mosqui-
toes in Gulu, Uganda, in 1959 (4) and has been responsi-
ble for several outbreaks in humans that occurred in East
Africa (Kenya, Uganda, Tanzania, Malawi, Mozambique).
Fever, headache, joint pains, and rash were the principal
signs and symptoms (5,6). Virus isolations from human
and animal sera as well as from Anopheles funestus and A.
gambiae have been reported in East Africa (7,8). Human
and animal infections based on serologic evidence have
also been reported in Nigeria, Ghana, and Sierra Leone
(9,10). ONNV was also isolated from sentinel mice in
Senegal and caused an outbreak in Côte d’Ivoire in the
1980s (11). To our knowledge, ONNV had never before
been isolated in Chad.
The Sarh region, where the patient was infected, con-
sists predominantly of plains covered with a mixture of
grasses and woodlands. This region receives heavy rainfall
during the 6-month rainy season, from May to October. To
our knowledge, no recent data are available concerning the
presence of Anopheles spp. in this region. Patient infection
occurred outside any reported outbreak involving ONNV
or another arbovirus. Moreover, the mission involved 9
other French soldiers whose serum specimens, collected a
few weeks after their return from Sarh and transported to
our laboratory, did not show serologic evidence of infec-
tion with an alphavirus.
SFV antibodies failed to detect ONNV by IFA,
although both viruses are members of the same antigenic
complex (12). The distribution of ONNV strains observed
in the phylograms seemed to be independent of viral isola-
tion locations or years. This finding suggests either a high
level of viral genomic sequence stability over time or the
circulation of ONNV strains across Africa, which has
given rise to a mixing of ONNV strains from different ori-
gins in the same areas. However, because of the limited
number of sequences available for genetic comparison,
this observation on the distribution of ONNV strains needs
confirmation.
In the absence of virus isolation, the diagnosis of infec-
tions with ONNV is difficult because of the close antigenic
relationship of this virus with other alphaviruses, especial-
ly CHIKV. Development of a specific serologic assay for
ONNV within the SFV antigenic complex would be a
valuable tool for diagnosis and surveillance studies.
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O’nyong-nyong virus
[o-nyong′ ′nyong]
O’nyong-nyong means “severe joint pain” in the
language of the Acholi people of East Africa.
O'nyong-nyong virus was first isolated in
Uganda in 1959 at the beginning of an outbreak
that spread to Kenya, Tanzania, Zaire, Malawi,
and Mozambique. One of the largest arbovirus
epidemics ever recorded, the outbreak lasted
until 1962 and affected >2 million persons. A
species of the genus Alphavirus and closely relat-
ed to chikungunya virus, O’nyong-nyong virus is
transmitted by the bite of anopheline mosquitoes
and causes an acute, self-limited, febrile illness
characterized by lymphadenitis and joint pain.
Sources: Dorland's illustrated medical dictionary. 30th ed.
Philadelphia: Saunders; 2003 and wikipedia.org
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